For instance, though the expression and activity of IRPs in cancer differ by tumor type, the overexpression of IRP2 has been observed at a preclinical level in many cancer cells and is correlated with altered iron phenotypes, while the downregulation of IRP1 has been linked in clinical studies with a poor prognosis of cancer progression [83,84]. Here, IREB2 is linked to cancer.